About Elevexo®
The Science of Exosome Therapy — How Elevexo® Formulations Work
Elevexo® is an FDA-compliant cosmetic Topical Product, ensuring safety and regulatory trust, designed to maximize the cell-signaling capabilities of exosomes, delivering the regenerative effects of amniotic fluid and Wharton’s Jelly via the FDA-cleared NanoPen®. A topical cosmetic with unadulterated Exosomes derived from pure amniotic fluid suspension and umbilical cord Wharton’s Jelly.
Averaging 70 billion protein particles carrying diverse exosome cargo such as miRNA, mRNA, proteins, lipids, growth factors, peptides, extracellular matrix components, collagens, and hyaluronic acid. Packaged in 5mL lyophilized vials, produced under cGMP and cGTP standards, with rigorous quality control systems and licensed across all relevant states to ensure consistent safety and quality.
What Are Exosomes and Why Do They Matter in Regenerative Therapy?
Exosomes are nanoscale extracellular vesicles released by cells to communicate with one another. Each carries a payload of growth factors, peptides, and signalling molecules that instruct surrounding cells how to repair, regenerate, and function. In regenerative medicine, this makes exosomes uniquely valuable: rather than delivering a single active ingredient, they transmit a coordinated set of biological signals that reflect the way the body naturally orchestrates healing.
Elevexo® formulations are built on exosome therapy derived from MSC Wharton’s Jelly — a rich, well-characterised source of mesenchymal signalling factors. By harnessing these signals, exosome therapy supports the cellular processes behind healthy hair and skin renewal. Understanding what exosomes are and how they work is the foundation for understanding why Elevexo’s science-led approach is designed to support regeneration at the source, giving clinics an evidence-informed basis for their treatment protocols.
Pharmaceutical-Grade Exosome Topical — Produced Under cGMP & cGTP Standards
Elevexo® formulations are produced to pharmaceutical-grade standards, giving clinics confidence in both quality and consistency. Each exosome topical is manufactured under cGMP (current Good Manufacturing Practice) and cGTP (current Good Tissue Practice) standards, ensuring rigorous control at every stage of production.
Every vial contains approximately 70 billion protein particles, delivered in a lyophilised (freeze-dried) format within 5mL vials to preserve stability and potency until the point of use. This manufacturing discipline reflects Elevexo’s commitment to trust, traceability, and clinical reliability. For licensed professionals, it means every formulation meets the exacting quality benchmarks expected of a regenerative product intended for use in a professional clinical environment.
Elevexo®'s Scientific Framework for Exosome Therapy
Growth Factor Signaling — How It Powers Hair & Skin Regeneration
Growth factors work by supporting the natural communication between cells, helping coordinate the biological processes involved in healthy tissue maintenance and regeneration. Rather than acting independently, they interact with surrounding cells to support a balanced regenerative environment for both hair follicles and skin. In Elevexo® formulations, multiple growth factors are combined with complementary regenerative ingredients to create a science-driven approach for professional clinical use. This integrated strategy supports advanced hair restoration and skin rejuvenation protocols while aligning with the body's natural signaling mechanisms.
Biomimetic Peptides — Engineered to Mimic Natural Biological Signals
Biomimetic peptides are laboratory-designed molecules that imitate naturally occurring biological signals within the body. They are developed to support normal cellular communication by resembling the signaling mechanisms involved in tissue maintenance and repair. Because they are modeled after naturally occurring peptides, they can be incorporated into regenerative formulations designed for professional clinical use. Within Elevexo® formulations, biomimetic peptides complement growth factors by supporting coordinated cellular signaling. Together, these components contribute to a science-based approach focused on maintaining healthy hair follicles and supporting skin regeneration through advanced regenerative technology.
Microenvironment Optimization — PDRN, Hyaluronic Acid & Adenosine
A healthy cellular microenvironment plays an important role in supporting the natural regenerative processes of both hair follicles and skin tissue. Ingredients such as PDRN, hyaluronic acid, and adenosine are commonly used in regenerative formulations to help maintain hydration, support tissue quality, and create favorable conditions for normal cellular activity. Elevexo® combines these supportive ingredients to optimize the environment surrounding hair follicles and skin cells. By helping maintain moisture balance and supporting tissue integrity, these compounds complement the formulation's broader regenerative strategy and enhance its integration into professional clinical protocols.
Synergistic Formulation Design — Every Ingredient Has a Role
Effective regenerative formulations rely on the interaction of multiple ingredient categories rather than a single active component. Growth factors, biomimetic peptides, and supportive compounds each perform distinct functions, but together they create a more comprehensive regenerative approach. This coordinated design allows the formulation to address multiple aspects of cellular signaling and tissue support simultaneously. Elevexo® follows this synergistic formulation philosophy by combining scientifically selected ingredients into an integrated professional solution. The result is a balanced regenerative formulation designed to support advanced hair restoration and skin rejuvenation protocols in clinical settings.
Clinical Integration — How Elevexo® Exosome Therapy Fits Your Practice
Elevexo works closely with medical professionals to align each formulation with real-world procedural workflows. Both EleveXo H and EleveXo S complement in-clinic regenerative modalities, offering providers a structured, science-driven addition to their treatment protocols.